Emilie P Belley-Cote1,2,3, André Lamy3,4, P J Devereaux1,2,3, Peter Kavsak5, François Lamontagne6, Deborah J Cook1,2, Kevin Kennedy1, Jessica Vincent3, Yongning Ou3, George Tagarakis7, Richard P Whitlock1,3,4. 1. Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada. 2. Department of Medicine, McMaster University, Hamilton, ON, Canada. 3. Population Health Research Institute, Hamilton, ON, Canada. 4. Department of Surgery, McMaster University, Hamilton, ON, Canada. 5. Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. 6. Department of Medicine, Université de Sherbrooke, Sherbrooke, QC, Canada. 7. Cardiothoracic Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Abstract
OBJECTIVES: Using data from the CORONARY trial (n = 4752), we evaluated the incidence and prognostic significance of myocardial infarction (MI) applying different definitions based on peak postoperative creatine kinase-MB isoenzyme and cardiac troponin levels. We then aimed to identify the peak cardiac troponin during the first 3 postoperative days that was independently associated with a 2-fold increase in 30-day mortality. METHODS: To combine different assays, we analysed cardiac troponins in multiples of their respective upper limit of normal (ULN). We identified the lowest threshold with a hazard ratio (HR) >2 for 30-day mortality independent of EuroSCORE and on- versus off-pump surgery. RESULTS: Depending on the definition used based on creatine kinase-MB, the incidence of MI after coronary artery bypass grafting (CABG) ranged from 0.6% to 19% and the associated HRs for 30-day mortality ranged from 2.7 to 6.9. Using cardiac troponin (1528 patients), the incidence of MI ranged from 1.7% to 13% depending on the definition used with HRs for 30-day mortality ranging from 5.1 to 7.2. The first cardiac troponin threshold we evaluated, 180xULN, was associated with an adjusted HR for 30-day mortality of 7.6 [95% confidence interval (CI) 3.4-17.1] when compared to <130xULN. The next independent threshold was 130xULN with an adjusted HR for 30-day mortality of 7.8 (95% CI 2.3-26.1). The next cardiac troponin tested threshold (70xULN) did not meet criteria for significance. CONCLUSIONS: Our results illustrate that the incidence and prognosis of a post-CABG MI varies based on the definition used. Validated post-CABG MI diagnostic criteria formulated from their independent association with important clinical outcomes are needed.
OBJECTIVES: Using data from the CORONARY trial (n = 4752), we evaluated the incidence and prognostic significance of myocardial infarction (MI) applying different definitions based on peak postoperative creatine kinase-MB isoenzyme and cardiac troponin levels. We then aimed to identify the peak cardiac troponin during the first 3 postoperative days that was independently associated with a 2-fold increase in 30-day mortality. METHODS: To combine different assays, we analysed cardiac troponins in multiples of their respective upper limit of normal (ULN). We identified the lowest threshold with a hazard ratio (HR) >2 for 30-day mortality independent of EuroSCORE and on- versus off-pump surgery. RESULTS: Depending on the definition used based on creatine kinase-MB, the incidence of MI after coronary artery bypass grafting (CABG) ranged from 0.6% to 19% and the associated HRs for 30-day mortality ranged from 2.7 to 6.9. Using cardiac troponin (1528 patients), the incidence of MI ranged from 1.7% to 13% depending on the definition used with HRs for 30-day mortality ranging from 5.1 to 7.2. The first cardiac troponin threshold we evaluated, 180xULN, was associated with an adjusted HR for 30-day mortality of 7.6 [95% confidence interval (CI) 3.4-17.1] when compared to <130xULN. The next independent threshold was 130xULN with an adjusted HR for 30-day mortality of 7.8 (95% CI 2.3-26.1). The next cardiac troponin tested threshold (70xULN) did not meet criteria for significance. CONCLUSIONS: Our results illustrate that the incidence and prognosis of a post-CABG MI varies based on the definition used. Validated post-CABG MI diagnostic criteria formulated from their independent association with important clinical outcomes are needed.
Authors: F Roques; S A Nashef; P Michel; E Gauducheau; C de Vincentiis; E Baudet; J Cortina; M David; A Faichney; F Gabrielle; E Gams; A Harjula; M T Jones; P P Pintor; R Salamon; L Thulin Journal: Eur J Cardiothorac Surg Date: 1999-06 Impact factor: 4.191
Authors: André Lamy; P J Devereaux; Dorairaj Prabhakaran; David P Taggart; Shengshou Hu; Ernesto Paolasso; Zbynek Straka; Leopoldo S Piegas; Ahmet Ruchan Akar; Anil R Jain; Nicolas Noiseux; Chandrasekar Padmanabhan; Juan-Carlos Bahamondes; Richard J Novick; Prashant Vaijyanath; Sukesh Reddy; Liang Tao; Pablo A Olavegogeascoechea; Balram Airan; Toomas-Andres Sulling; Richard P Whitlock; Yongning Ou; Jennifer Ng; Susan Chrolavicius; Salim Yusuf Journal: N Engl J Med Date: 2012-03-26 Impact factor: 91.245
Authors: Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Kristian Thygesen; Joseph S Alpert; Harvey D White; Allan S Jaffe; Hugo A Katus; Fred S Apple; Bertil Lindahl; David A Morrow; Bernard A Chaitman; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Robert O Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasché; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; José-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michael Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis Journal: Eur Heart J Date: 2012-08-24 Impact factor: 29.983
Authors: C Rasmussen; J J Thiis; P Clemmensen; F Efsen; H C Arendrup; K Saunamäki; J K Madsen; G Pettersson Journal: Eur J Cardiothorac Surg Date: 1997-12 Impact factor: 4.191
Authors: Issam D Moussa; Lloyd W Klein; Binita Shah; Roxana Mehran; Michael J Mack; Emmanouil S Brilakis; John P Reilly; Gilbert Zoghbi; Elizabeth Holper; Gregg W Stone Journal: J Am Coll Cardiol Date: 2013-10-22 Impact factor: 24.094
Authors: P J Devereaux; Bruce M Biccard; Alben Sigamani; Denis Xavier; Matthew T V Chan; Sadeesh K Srinathan; Michael Walsh; Valsa Abraham; Rupert Pearse; C Y Wang; Daniel I Sessler; Andrea Kurz; Wojciech Szczeklik; Otavio Berwanger; Juan Carlos Villar; German Malaga; Amit X Garg; Clara K Chow; Gareth Ackland; Ameen Patel; Flavia Kessler Borges; Emilie P Belley-Cote; Emmanuelle Duceppe; Jessica Spence; Vikas Tandon; Colin Williams; Robert J Sapsford; Carisi A Polanczyk; Maria Tiboni; Pablo Alonso-Coello; Atiya Faruqui; Diane Heels-Ansdell; Andre Lamy; Richard Whitlock; Yannick LeManach; Pavel S Roshanov; Michael McGillion; Peter Kavsak; Matthew J McQueen; Lehana Thabane; Reitze N Rodseth; Giovanna A Lurati Buse; Mohit Bhandari; Ignacia Garutti; Michael J Jacka; Holger J Schünemann; Olga Lucía Cortes; Pierre Coriat; Nazari Dvirnik; Fernando Botto; Shirley Pettit; Allan S Jaffe; Gordon H Guyatt Journal: JAMA Date: 2017-04-25 Impact factor: 56.272